Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 11;11(8):2209–2223. doi: 10.1111/1759-7714.13528

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

High mPRα expression is associated with poor prognosis in patients with lung adenocarcinoma. (a) The relationship between mPRα mRNA expression and prognosis in patients with lung adenocarcinoma (ai) and lung squamous cell carcinoma (aii) was analyzed by using HPA. (b) Typical images showing the IHC staining intensity of mPRα expression in different lung adenocarcinoma tissues. (bi & bii) Negative (paracancerous lung tissue); (biii & biv) weakly positive; (bv & bvi) moderately positive; (bvii & bviii) strongly positive. (c) Kaplan‐Meier analysis results showed that high expression of mPRα protein in lung adenocarcinoma patients (n = 75) is associated with poor overall survival prognosis () Low expression, () High expression. mPRα, membrane progesterone receptor alpha; HPA, Human Pathology Atlas; IHC, immunohistochemistry.

Inline graphic — High mPRα expression is associated with poor prognosis in patients with lung adenocarcinoma. (a) The relationship between mPRα mRNA expression and prognosis in patients with lung adenocarcinoma (ai) and lung squamous cell carcinoma (aii) was analyzed by using HPA. (b) Typical images showing the IHC staining intensity of mPRα expression in different lung adenocarcinoma tissues. (bi & bii) Negative (paracancerous lung tissue); (biii & biv) weakly positive; (bv & bvi) moderately positive; (bvii & bviii) strongly positive. (c) Kaplan‐Meier analysis results showed that high expression of mPRα protein in lung adenocarcinoma patients (n = 75) is associated with poor overall survival prognosis () Low expression, () High expression. mPRα, membrane progesterone receptor alpha; HPA, Human Pathology Atlas; IHC, immunohistochemistry.